Article
Advanced age impairs cardioprotective function of mesenchymal stem cell transplantation from patients to myocardially infarcted rats.
Cardiology - 1 Jan 2014
Liu Yu, Liu Tao, Han Jinsong, Yang Zhonglu, Xue Xiaodong, Jiang Hui, Wang Huishan
Abstract excerpt
OBJECTIVES: Mesenchymal stem cells (MSCs) have limited clinical therapeutic effects in older myocardial infarction (MI) patients. Thus, whether younger MSCs might confer greater protection is worth investigating. METHODS: Human MSCs (hMSCs) were isolated before coronary artery bypass graft surgery and growth characteristics of hMSCs at passage 3 were observed. Vascular endothelial growth factor (VEGF) and Bcl-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
